TransCelerate BioPharma
Karin Kramer Nielsen holds an MSc and Ph.D. in Clinical Pharmacology from the University of Southern Denmark. After completing her academic education, Karin was appointed Assistant Professor and later Associated Professor. Since 1994 Karin has been employed at Novo Nordisk where she has held several specialist positions and since 2000 various leadership positions across the R&D value chain. Currently, Karin is leading the Novo Nordisk Data Management organization as Corporate Vice President.
Karin joined TransCelerate as an ILT member in 2019 and since June 2021 has been the Chairperson of the TransCelerate Clinical Oversight Committee.
This person is not in the org chart
This person is not in any offices
TransCelerate BioPharma
TransCelerate BioPharma Inc. was launched in 2012 as a non-profit organization to improve the health of people around the world by accelerating and enhancing the research and development of innovative new therapies.